Survival of chronic myeloid leukemia patients in comparison to the general population in the tyrosine kinase inhibitors era: A US population-based study

被引：4
|
作者：
Jamy, Omer [1 ]
Godby, Richard [2 ]
Sarmad, Rehan [1 ]
Costa, Luciano J. [1 ]
机构：
[1] Univ Alabama Birmingham, Dept Med, Div Hematol & Oncol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2021年 / 96卷 / 07期
关键词：
D O I：
10.1002/ajh.26195
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E265 / E268
页数：4
相关论文
共 50 条
  • [1] Survival of Chronic Myeloid Leukemia Patients in Comparison to General Population in the Tyrosine Kinase Inhibitors Era: A US Population Based Study
    Sarmad, Rehan
    Jamy, Omer
    Costa, Luciano J.
    BLOOD, 2017, 130
  • [2] The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: a population-based study
    Di Felice, Enza
    Roncaglia, Francesca
    Venturelli, Francesco
    Mangone, Lucia
    Luminari, Stefano
    Cirilli, Claudia
    Carrozzi, Giuliano
    Rossi, Paolo Giorgi
    BMC CANCER, 2018, 18
  • [3] The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: a population-based study
    Enza Di Felice
    Francesca Roncaglia
    Francesco Venturelli
    Lucia Mangone
    Stefano Luminari
    Claudia Cirilli
    Giuliano Carrozzi
    Paolo Giorgi Rossi
    BMC Cancer, 18
  • [4] Chronic Myeloid Leukemia in Chronic Phase: Survival in the Era of Tyrosine Kinase Inhibitors Is Similar to That of the General Population in All Age Groups
    Sasaki, Koji
    Strom, Sara S.
    O'Brien, Susan
    Jabbour, Elias
    Ravandi, Farhad
    Konopleva, Marina
    Borthakur, Gautam
    Pemmaraju, Naveen
    Daver, Naval
    Pierce, Sherry R.
    Kantarjian, Hagop M.
    Cortes, Jorge E.
    BLOOD, 2014, 124 (21)
  • [5] Conditional relative survival among adult patients with chronic myeloid leukemia in the tyrosine kinase inhibitor era: a population-based study in the Netherlands
    Geneviève I. C. G. Ector
    Otto Visser
    Eduardus F. M. Posthuma
    Peter E. Westerweel
    Jeroen J. W. M. Janssen
    Nicole M. A. Blijlevens
    Avinash G. Dinmohamed
    Leukemia, 2021, 35 : 3291 - 3294
  • [6] Conditional relative survival among adult patients with chronic myeloid leukemia in the tyrosine kinase inhibitor era: a population-based study in the Netherlands
    Ector, Genevieve I. C. G.
    Visser, Otto
    Posthuma, Eduardus F. M.
    Westerweel, Peter E.
    Janssen, Jeroen J. W. M.
    Blijlevens, Nicole M. A.
    Dinmohamed, Avinash G.
    LEUKEMIA, 2021, 35 (11) : 3291 - 3294
  • [7] The treatment of patients with chronic myeloid leukemia chronic phase combined with myelofibrosis with tyrosine kinase inhibitors: A Chinese population-based study
    Zhang, Xinlu
    Yang, Xiudi
    Chen, Dan
    Wang, Yi
    Feng, Weiying
    Lu, Ying
    Qian, Honglan
    Zhou, Mei
    Chen, Yu
    Wu, Dijiong
    Liu, Lirong
    Tong, Hongyan
    Jin, Jie
    Huang, Jian
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Cardiovascular Events Associated With Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia A Population-Based Cohort Study
    Dahlen, Torsten
    Edgren, Gustaf
    Lambe, Mats
    Hoglund, Martin
    Bjorkholm, Magnus
    Sandin, Fredrik
    Sjalander, Anders
    Richter, Johan
    Olsson-Stromberg, Ulla
    Ohm, Lotta
    Back, Magnus
    Stenke, Leif
    ANNALS OF INTERNAL MEDICINE, 2016, 165 (03) : 161 - +
  • [9] Conditional survival in patients with chronic myeloid leukemia in chronic phase in the era of tyrosine kinase inhibitors
    Sasaki, Koji
    Kantarjian, Hagop M.
    Jain, Preetesh
    Jabbour, Elias J.
    Ravandi, Farhad
    Konopleva, Marina
    Borthakur, Gautam
    Takahashi, Koichi
    Pemmaraju, Naveen
    Daver, Naval
    Pierce, Sherry A.
    O'Brien, Susan M.
    Cortes, Jorge E.
    CANCER, 2016, 122 (02) : 238 - 248
  • [10] Tyrosine Kinase Inhibitors and Vascular Adverse Events in Patients with Chronic Myeloid Leukemia: A Population-Based, Propensity Score-Matched Cohort Study
    Chen, Mei-Tsen
    Huang, Shih-Tsung
    Lin, Chih-Wan
    Ko, Bor-Sheng
    Chen, Wen-Jone
    Huang, Huai-Hsuan
    Hsiao, Fei-Yuan
    ONCOLOGIST, 2021, 26 (11): : 974 - 982
12345